valbenazine
Ligand Summary
The mechanism of action of valbenazine in the treatment of tardive dyskinesia is unknown, but is thought to be mediated through the reversible inhibition of vesicular monoamine transporter 2 (VMAT2), a transporter that regulates monoamine uptake from the cytoplasm to the synaptic vesicle for storage and release.
UNII: 54K37P50KH
PubChem: 24795069
Guide to Pharmacology: 8694
ChEMBL: CHEMBL2364639
DrugCentral: 5227
LyCHI: RH92VMZKBD3A
Target Activities
3 Activities
Items per page:
10
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
IC50 | ||||||
Ki | INHIBITOR | |||||